TDC
ESRX

Thompson Davis & Co’s Express Scripts Holding Company ESRX Stock Holding History

Thompson Davis & Co’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-276
Closed -$17K – 1201
2017
Q3 		$17K Hold
276
– – 0.03% 537
2017
Q2 		$18K Buy
276
+30
+12% +$1.88K 0.03% 511
2017
Q1 		$16K Sell
246
-2
-0.8% -$138 0.02% 575
2016
Q4 		$17K Buy
248
+25
+11% +$1.79K 0.03% 555
2016
Q3 		$16K Sell
223
-292
-57% -$21.8K 0.03% 549
2016
Q2 		$39K Sell
515
-556
-52% -$40.9K 0.06% 295
2016
Q1 		$74K Buy
1,071
+282
+36% +$20.3K 0.11% 184
2015
Q4 		$69K Sell
789
-18
-2% -$1.54K 0.1% 212
2015
Q3 		$65K Sell
807
-72
-8% -$6.27K 0.09% 213
2015
Q2 		$78K Sell
879
-10
-1% -$874 0.09% 233
2015
Q1 		$77K Sell
889
-1,481
-62% -$124K 0.09% 219
2014
Q4 		$201K Buy
2,370
+1,648
+228% +$129K 0.23% 87
2014
Q3 		$51K Buy
+722
New +$51.4K 0.07% 265

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Thompson Davis & Co's ESRX Position: Q4 2017 in Review

Thompson Davis & Co sold out of Express Scripts Holding Company (ESRX) in Q4 2017, closing a stake of 276 shares — an estimated $17K sold.

Thompson Davis & Co first reported a position in ESRX in Q3 2014 and held it in 13 quarters. The position peaked at $201K in Q4 2014. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q4 2017.

  • Thompson Davis & Co reported no remaining Express Scripts Holding Company position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 276 Express Scripts Holding Company shares in Q4 2017, an estimated $17K.
  • Thompson Davis & Co first reported a position in Express Scripts Holding Company in Q3 2014 and held it in 13 quarters.
  • Thompson Davis & Co's Express Scripts Holding Company position peaked at $201K in Q4 2014.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.